Endometriosis Awareness Month – March into Yellow
This Endometriosis Awareness Month, Endometriosis Australia is calling for everyone to ‘March into Yellow’ to raise awareness of endometriosis and encourage public discussion on the largely invisible illness. Endometriosis affects more than 830,000 women in Australia and occurs when tissue, similar to the uterus lining, forms outside of the womb, growing around the ovaries, bowel…
The critical role of empathy in effective communications
Empathy is key to effective healthcare communication. The ability to put oneself in another’s shoes, trying to understand what they may be feeling, and acknowledging the significant impact an illness or life event can have on a person’s wellbeing is crucial to building trust and connecting in a meaningful way. Every day, the VIVA! team…
World’s Greatest Shave
Did you know, 47 Australians are diagnosed with blood cancer every day? That’s one person every 31 minutes. According to The Leukaemia Foundation, this figure is set to increase to 100 by 2035. This week marks the World’s Greatest Shave, an initiative run by the Leukaemia Foundation to help raise funds and support those living…
VIVA! talks to Professor Anna DeFazio about Ovarian Cancer
February is Ovarian Cancer Awareness month, dedicated to raising much needed awareness and funds for research to improve management of this deadly disease and providing support for women diagnosed and their families. This week, we spoke with Professor Anna DeFazio – the Sydney-West Chair in Translational Cancer Research, The University of Sydney and Director of…
It’s not goodbye, it’s see you later
Regulatory codes, compliance teams, acronyms and writing gut-wrenching patient case studies were probably the first and hardest things to get my head around when I jumped headfirst into the healthcare industry and life at VIVA! Communications almost four years ago. As a Brit coming Down Under from an in-house role in the sports industry, there…
Launch of GLOBALHealthPR’s ‘Global Guide to Market Access’
New resource enabling biopharma industry to navigate access & reimbursement landscape across 26 countries GLOBALHealthPRTM (GHPR) – the world’s largest independent health and science communications agency partnership – has today launched the Global Guide to Market Access – an invaluable industry resource providing local insights into the biopharmaceutical reimbursement landscape in 26 countries. VIVA! Communications…
VIVA! appoints Julia Slater as GM
VIVA! Communications (VIVA!) has today announced the appointment of Julia Slater as General Manager (GM) of the award-winning, independent, Australian health + wellness communications agency and Asia Pacific hub lead for GLOBALHealthPR. Julia brings more than a decade of PR and communications experience to her new role, to support VIVA!’s recent, unparalleled local and international…
Nation’s staggering 173,000 broken bones prompts urgent call to prioritise bone health
Osteoporosis Australia rebrands as ‘Healthy Bones Australia’ & launches educational resource hub Osteoporosis Australia announced its official rebrand as ‘Healthy Bones Australia’ today (Tuesday, February 9) to reinforce the importance of prevention, in response to the concerning 173,000 broken bones sustained by the Australian population last year. The patient organisation also called for Australians to…
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Launch of first pan-Asia Pacific minimum clinical standards for the screening, diagnosis & management of osteoporosis The Asia Pacific Consortium on Osteoporosis (APCO) has today (Thursday, January 28, 2021) launched the first pan-Asia Pacific clinical practice standards for the screening, diagnosis, and management of osteoporosis, targeting a broad range of high-risk groups. Published in Osteoporosis International…
COVID-19 vaccine update
The urgency posed by the COVID-19 pandemic has seen some of the world’s leading research teams working tirelessly to find a vaccine for the virus. Impressively, while most vaccines require years of research and testing, this has facilitated the development of multiple COVID-19 vaccines in a matter of months, with many trials still in progress.…